Casamenti F, Corradetti R, Löffelholz K, Mantovani P, Pepeu G
Br J Pharmacol. 1982 Jul;76(3):439-45. doi: 10.1111/j.1476-5381.1982.tb09237.x.
1 The effects of 4-aminopyridine (4AP) on the output of acetylcholine (ACh) from the cerebral cortex were investigated in unanaesthetized freely moving rats and in anaesthetized rats by means of the ;cup technique'. ACh was determined by bioassay on the dorsal muscle of the leech.2 In unanaesthetized rats intraperitoneal injection of 4AP (3 mg/kg) had no effect on the cortical output of ACh.3 After injection of morphine (10 mg/kg s.c.), which depressed the spontaneous output of ACh, 4AP increased the cortical output to a level significantly higher than that determined before morphine injection.4 In rats anaesthetized with either urethane or pentobarbitone, drugs known to decrease cortical output of ACh, 4AP (i.v. or i.p.) elicited a significant increase in the output of ACh. The time-courses of the 4AP-induced effects were different depending on the anaesthetic drug used: an immediate increase slowly fading in urethane anaesthesia and a gradual increase after delayed onset in pentobarbitone-anaesthetized rats.5 In some urethane-anaesthetized rats, respiratory frequency was kept constant (tracheotomy, connection to respirator, bilateral vagotomy) and prazosin (1 mg/kg i.v.) was administered to reduce the 4AP-induced increase of blood pressure. Cortical output of ACh was not related to changes in blood pressure. Moreover, the 4AP-induced increase in cortical ACh output was not related to changes in respiratory frequency.6 In summary systemic administration of 4AP in subconvulsive doses (1 and 3 mg/kg) increased cortical output of ACh in rats anaesthetized with urethane or pentobarbitone or after injection of morphine, but not in untreated freely moving rats. It is suggested that the anaesthetic agents and morphine may cause an imbalance between excitatory and inhibitory central pathways, and that this imbalance may play a role in their depressant effect on cortical output of ACh and/or in the 4AP-induced facilitation described in this paper.
采用“杯技术”,在未麻醉的自由活动大鼠和麻醉大鼠中研究了4-氨基吡啶(4AP)对大脑皮质乙酰胆碱(ACh)释放量的影响。通过对水蛭背肌进行生物测定来确定ACh的含量。
在未麻醉的大鼠中,腹腔注射4AP(3毫克/千克)对皮质ACh释放量没有影响。
注射吗啡(10毫克/千克,皮下注射)后,ACh的自发释放量降低,而4AP可使皮质释放量增加至显著高于吗啡注射前测定的水平。
在使用乌拉坦或戊巴比妥麻醉的大鼠中,已知这些药物会降低皮质ACh释放量,静脉注射或腹腔注射4AP会使ACh释放量显著增加。4AP诱导的效应的时间进程因所用麻醉药物而异:在乌拉坦麻醉下立即增加并缓慢消退,在戊巴比妥麻醉的大鼠中延迟发作后逐渐增加。
在一些乌拉坦麻醉的大鼠中,保持呼吸频率恒定(气管切开、连接呼吸机、双侧迷走神经切断),并静脉注射哌唑嗪(1毫克/千克)以降低4AP引起的血压升高。皮质ACh释放量与血压变化无关。此外,4AP引起的皮质ACh释放量增加与呼吸频率变化无关。
总之,以亚惊厥剂量(1和3毫克/千克)全身给药4AP,可增加用乌拉坦或戊巴比妥麻醉的大鼠或注射吗啡后的皮质ACh释放量,但对未处理的自由活动大鼠无效。提示麻醉剂和吗啡可能导致兴奋性和抑制性中枢通路之间失衡,这种失衡可能在它们对皮质ACh释放量的抑制作用和/或本文所述的4AP诱导的促进作用中起作用。